Literature DB >> 17366691

Should terminally ill patients have access to phase I drugs?

Nellie Bristol.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17366691     DOI: 10.1016/S0140-6736(07)60390-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Ethics, error, and initial trials of efficacy.

Authors:  Spencer Phillips Hey; Jonathan Kimmelman
Journal:  Sci Transl Med       Date:  2013-05-08       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.